Geron Corp's shares rose 50% after the company announced that its experimental blood cancer drug helped more patients achieve blood transfusion independence when compared to a placebo in a late-stage trial. Imetelstat, Geron's lead drug, was being...
Everest Medicines, a biopharmaceutical company, has announced its strategic plans for the next two years and beyond, as the company strives to become a fully-integrated biopharmaceutical company with expertise and capabilities spanning the entire...
Granules India Limited, enters into a strategic partnership with Greenko ZeroC to collaborate for green molecule solutions and its wider applications in pharmaceuticals to build a leadership position in sustainability and circular economy...
BDR Pharmaceutical has launched the first generic Apalutamide (Brand name Apatide) in India to treat metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). ..
Zydus Lifesciences Ltd said it has received final approval from the US health regulator to market its generic version of Triazolam tablets used on a short-term basis to treat insomnia. The approval granted by the US Food and Drug Administration...
The government said it has signed a pact with the Pune-based Institute of Veterinary Biological Products (IVBP) for commercial production of indigenously developed vaccine 'Lumpi-ProVac' for the control of lumpy skin disease in cattle...
Cipla said that its wholly owned UK subsidiary has signed definitive agreements for equity investment of EUR 15 million in Ethris, a global leader in delivering mRNAs directly to the respiratory system including administration by inhalation...
In this article we have combined four promising trends in SUT that is expected to have a lasting impact on the pharmaceutical industry.
India is likely to get an Omicron-specific booster shot soon. Gennova Biopharmaceuticals, subsidiary of Pune-based drug maker Emcure, will soon submit data of clinical trials conducted on its mRNA vaccine that will target the Omicron variant of...
Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received...
, CDSCO.jpg)
